Marjukka Kolehmainen

Prof. Dr. Marjukka Kolehmainen

Department of Clinical Nutrition, University of Eastern Finland, Kuopio, Finland
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Kati HanhinevaKati Hanhineva
Kati Hanhineva
RTRiitta Törrönen
Riitta Törrönen
IBIsabel Bondia-Pons
Isabel Bondia-Pons
JPJenna Pekkinen
Jenna Pekkinen
Marjukka KolehmainenMarjukka Kolehmainen
Marjukka Kolehmainen
KPKaisa Poutanen
Kaisa Poutanen
Polyphenols, including flavonoids, phenolic acids, proanthocyanidins and resveratrol, are a large and heterogeneous group of phytochemicals in plant-based foods, such as tea, coffee, wine, cocoa, cereal grains, soy, fruits and berries. Growing evidence indicates that various dietary polyphenols may influence carbohydrate metabolism at many levels. In animal models and a limited number of human studies carried out so far, polyphenols and foods or beverages rich in polyphenols have attenuated postprandial glycemic responses and fasting hyperglycemia, and improved acute insulin secretion and insulin sensitivity. The possible mechanisms include inhibition of carbohydrate digestion and glucose absorption in the intestine, stimulation of insulin secretion from the pancreatic b-cells, modulation of glucose release from the liver, activation of insulin receptors and glucose uptake in the insulin-sensitive tissues, and modulation of intracellular signalling pathways and gene expression. The positive effects of polyphenols on glucose homeostasis observed in a large number of in vitro and animal models are supported by epidemiological evidence on polyphenol-rich diets. To confirm the implications of polyphenol consumption for prevention of insulin resistance, metabolic syndrome and eventually type 2 diabetes, human trials with well-defined diets, controlled study designs and clinically relevant end-points together with holistic approaches e.g., systems biology profiling technologies are needed.

4 May 2022 in Nutrition Reviews
Verified
Journal Article
Open access
PDF file
KPKaisa S Poutanen
Kaisa S Poutanen
AKAnna O Kårlund
Anna O Kårlund
CGCarlos Gómez-Gallego
Carlos Gómez-Gallego
DJDaniel P Johansson
Daniel P Johansson
NSNathalie M Scheers
Nathalie M Scheers
RIkard LandbergRIkard Landberg
RIkard Landberg
Cereal grains are the main dietary source of energy, carbohydrates, and plant proteins world-wide. Currently, only 41% of grains are used for human consumption, and up to 35% are used for animal feed. Cereals have been overlooked as a source of environmentally sustainable and healthy plant proteins and could play a major role in transitioning towards a more sustainable food system for healthy diets. Cereal plant proteins are of good nutritional quality, but lysine is often the limiting amino acid. When consumed as whole grains, cereals provide health-protecting components such as dietary fiber and phytochemicals. Shifting grain use from feed to traditional foods and conceptually new foods and ingredients could improve protein security and alleviate climate change. Rapid development of new grain-based food ingredients and use of grains in new food contexts, such as dairy replacements and meat analogues, could accelerate the transition. This review discusses recent developments and outlines future perspectives for cereal grain use.

11 October 2019 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MKMarietta Kokla
Marietta Kokla
JVJyrki Virtanen
Jyrki Virtanen
Marjukka KolehmainenMarjukka Kolehmainen
Marjukka Kolehmainen
JPJussi Paananen
Jussi Paananen
Kati HanhinevaKati Hanhineva
Kati Hanhineva
Background: LC-MS technology makes it possible to measure the relative abundance of numerous molecular features of a sample in single analysis. However, especially non-targeted metabolite profiling approaches generate vast arrays of data that are prone to aberrations such as missing values. No matter the reason for the missing values in the data, coherent and complete data matrix is always a pre-requisite for accurate and reliable statistical analysis. Therefore, there is a need for proper imputation strategies that account for the missingness and reduce the bias in the statistical analysis. Results: Here we present our results after evaluating nine imputation methods in four different percentages of missing values of different origin. The performance of each imputation method was analyzed by Normalized Root Mean Squared Error (NRMSE). We demonstrated that random forest (RF) had the lowest NRMSE in the estimation of missing values for Missing at Random (MAR) and Missing Completely at Random (MCAR). In case of absent values due to Missing Not at Random (MNAR), the left truncated data was best imputed with minimum value imputation. We also tested the different imputation methods for datasets containing missing data of various origin, and RF was the most accurate method in all cases. The results were obtained by repeating the evaluation process 100 times with the use of metabolomics datasets where the missing values were introduced to represent absent data of different origin. Conclusion: Type and rate of missingness affects the performance and suitability of imputation methods. RF-based imputation method performs best in most of the tested scenarios, including combinations of different types and rates of missingness. Therefore, we recommend using random forest-based imputation for imputing missing metabolomics data, and especially in situations where the types of missingness are not known in advance.

30 May 2018 in Genes & Nutrition
Verified
Journal Article
Open access
PDF file
Lars O. DragstedLars O. Dragsted
Lars O. Dragsted
QGQian Gao
Qian Gao
Augustin ScalbertAugustin Scalbert
Augustin Scalbert
GVGuy Vergères
Guy Vergères
Marjukka KolehmainenMarjukka Kolehmainen
Marjukka Kolehmainen
GPG. Praticò
G. Praticò
Biomarkers of food intake (BFIs) are a promising tool for limiting misclassification in nutrition research where more subjective dietary assessment instruments are used. They may also be used to assess compliance to dietary guidelines or to a dietary intervention. Biomarkers therefore hold promise for direct and objective measurement of food intake. However, the number of comprehensively validated biomarkers of food intake is limited to just a few. Many new candidate biomarkers emerge from metabolic profiling studies and from advances in food chemistry. Furthermore, candidate food intake biomarkers may also be identified based on extensive literature reviews such as described in the guidelines for Biomarker of Food Intake Reviews (BFIRev). To systematically and critically assess the validity of candidate biomarkers of food intake, it is necessary to outline and streamline an optimal and reproducible validation process. A consensus-based procedure was used to provide and evaluate a set of the most important criteria for systematic validation of BFIs. As a result, a validation procedure was developed including eight criteria, plausibility, dose-response, time-response, robustness, reliability, stability, analytical performance, and inter-laboratory reproducibility. The validation has a dual purpose: (1) to estimate the current level of validation of candidate biomarkers of food intake based on an objective and systematic approach and (2) to pinpoint which additional studies are needed to provide full validation of each candidate biomarker of food intake. This position paper on biomarker of food intake validation outlines the second step of the BFIRev procedure but may also be used as such for validation of new candidate biomarkers identified, e.g., in food metabolomic studies.

7 September 2012 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
Marjukka KolehmainenMarjukka Kolehmainen
Marjukka Kolehmainen
OMOtto Mykkänen
Otto Mykkänen
PKPirkka V. Kirjavainen
Pirkka V. Kirjavainen
TLTiina Leppänen
Tiina Leppänen
EMEeva Moilanen
Eeva Moilanen
RTRiitta Törrönen
Riitta Törrönen

10 January 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
NSNiina Siitonen
Niina Siitonen
LPLeena Pulkkinen
Leena Pulkkinen
JLJaana Lindström
Jaana Lindström
Marjukka KolehmainenMarjukka Kolehmainen
Marjukka Kolehmainen
JEJohan Gunnar Eriksson
Johan Gunnar Eriksson
Matti UusitupaMatti Uusitupa
Matti Uusitupa
Adiponectin, secreted mainly by mature adipocytes, is a protein with insulin-sensitising and anti-atherogenic effects. Human adiponectin is encoded by the ADIPOQ gene on the chromosomal locus 3q27. Variations in ADIPOQ are associated with obesity, type 2 diabetes (T2DM) and related phenotypes in several populations. Our aim was to study the association of the ADIPOQ variations with body weight, serum adiponectin concentrations and conversion to T2DM in overweight subjects with impaired glucose tolerance. Moreover, we investigated whether ADIPOQ gene variants modify the effect of lifestyle changes on these traits.